Discovery of novel quinoline scaffold selective estrogen receptor degraders (SERDs) for treatment of ER positive breast cancer with enhanced antiproliferative bioactivity through immunogenic cell death (ICD) effects

Update your browser to view ScienceDirect.

Request details:

Request ID: 89342dc2b96bcf97-SJC
IP: 116.62.10.13
UTC time: 2024-06-13T18:35:08+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4